Original Research
Published on 27 Oct 2022
in Cancer Endocrinology
Original Research
Published on 26 Oct 2022
in Cancer Endocrinology
Original Research
Published on 25 Oct 2022
in Cancer Endocrinology
Original Research
Published on 24 Oct 2022
in Cancer Endocrinology
Editorial
Published on 24 Oct 2022
in Cancer Endocrinology
Original Research
Published on 24 Oct 2022
in Cancer Endocrinology
Original Research
Published on 21 Oct 2022
in Cancer Endocrinology
Systematic Review
Published on 20 Oct 2022
in Cancer Endocrinology
Editorial
Published on 20 Oct 2022
in Cancer Endocrinology
Original Research
Published on 19 Oct 2022
in Cancer Endocrinology
Original Research
Published on 18 Oct 2022
in Cancer Endocrinology
Original Research
Published on 18 Oct 2022
in Cancer Endocrinology
Editorial
Published on 18 Oct 2022
in Cancer Endocrinology
Review
Published on 17 Oct 2022
in Cancer Endocrinology
Original Research
Published on 17 Oct 2022
in Cancer Endocrinology
Original Research
Published on 14 Oct 2022
in Cancer Endocrinology
![Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review](https://www.frontiersin.org/files/myhome article library/957172/957172_Thumb_400.jpg)
